MolNFT v1 · #17403 · protein
Human HSP90 in complex with 17-desmethoxy-17-N,N- dimethylaminoethylamino-geldanamycin
1OSF · Heat shock 90KDA protein 1, alpha: “Human HSP90 in complex with 17-desmethoxy-17-N,N- dimethylaminoethylamino-geldanamycin”. X-ray diffraction, 1 ligand (KOS), 1 pocket (best druggability 0.62). MolNFT v1 #17403 on GenesisL1: 3D…
- PDB
- 1OSF
- Type
- protein
- Length
- 215 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Heat shock 90KDA protein 1, alpha
- UniProt
- P07900
- Ligands
- KOS
- Pockets
- 1 · best druggability 0.62
Structure
x-ray diffraction · 1 distinct chain · 40% helix, 22% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Heat shock 90KDA protein 1, alpha | protein | 215 | 40% helix, 22% strand | P07900 |
Ligands and binding sites
- KOS · 17-desmethoxy-17-N,N-dimethylaminoethylamino-geldanamycin · ligand · chains A
- MPD · (4S)-2-methyl-2,4-pentanediol · additive · 2 copies · chains A
- ACY · Acetic acid · additive · 2 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 258 | 0.62 | 0.81 | 27 | KOS |
Compared structures
- 1OSF · Human Hsp90 in complex with 17-desmethoxy-17-N,N-Dimethylaminoethylamino-Geldanamycin · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P07900
- Elsewhere: RCSB PDB 1OSF · PDBe 1OSF · UniProt P07900
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.